J&J Directors Find Root Causes But Little Blame For OTC Quality Issues
This article was originally published in The Pink Sheet Daily
Executive Summary
Report from a Johnson & Johnson special committee responds to shareholder demands and a shareholder lawsuit against J&J and members of the company's board of directors.